10x Genomics Raises 2026 Revenue Guidance to $625M–$635M
Q3 2026 revenue was $150.7 million, compared with $149.0 million a year earlier. The company expects 4%–6% revenue growth over 2025 excluding non-recurring patent-litigation settlement revenue in both years.
Q3 2026 revenue was $150.7M versus $149.0M a year earlier. 10x Genomics raised 2026 revenue guidance to $625M—$635M from $610M—$630M; excluding non-recurring patent-litigation settlement revenue in both years, it expects 4%—6% growth over 2025.Material DetailsContext by AI AnalystThis is a quarterl…